{"title":"Heart Disease After Covid: Exacerbated Future Health Risks Aligned to Previous and Existing AAS/Androgen Use","authors":"P. Crisp, Jamie Sims","doi":"10.2478/afepuc-2022-0012","DOIUrl":null,"url":null,"abstract":"Summary In this commentary/short communication we build upon our existing research and viewpoints related to the deleterious effects that AAS/Androgen use has, and the growing body of work and case studies/reports that identify the substantially increased risks that AAS/Androgen use presents to those who have (or have had) COVID-19. We position this commentary/short communication then, as one that builds on our prior calls for public health policy to be in part framed by, or at least to recognise the risks, of AAS/Androgen use. This is of particular contemporary importance now that COVID-19 is endemic, and we report on how long COVID-19 (Post COVID-19 syndrome) can present a wide range of lasting cardiovascular problems, a particular issue given that AAS/Androgen use may well exacerbate future health risks aligned to COVID-19.","PeriodicalId":31087,"journal":{"name":"Acta Facultatis Educationis Physicae Universitatis Comenianae","volume":"62 1","pages":"134 - 141"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Facultatis Educationis Physicae Universitatis Comenianae","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/afepuc-2022-0012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Summary In this commentary/short communication we build upon our existing research and viewpoints related to the deleterious effects that AAS/Androgen use has, and the growing body of work and case studies/reports that identify the substantially increased risks that AAS/Androgen use presents to those who have (or have had) COVID-19. We position this commentary/short communication then, as one that builds on our prior calls for public health policy to be in part framed by, or at least to recognise the risks, of AAS/Androgen use. This is of particular contemporary importance now that COVID-19 is endemic, and we report on how long COVID-19 (Post COVID-19 syndrome) can present a wide range of lasting cardiovascular problems, a particular issue given that AAS/Androgen use may well exacerbate future health risks aligned to COVID-19.